Annual EBITDA
-$2.86B$897.00M+23.88%
Summary
- Current Value
- As of today, MRNA annual EBITDA is -$2.86B, up +23.88% on
- Historical Performance
- MRNA annual EBITDA is down -129.74% over the past 3 years, down -290.63% over the past 5 years
- All-Time High Comparison
- MRNA annual EBITDA is currently -121.22% below its historical high of $13.47B set on
- 3-Year Low Comparison
- MRNA annual EBITDA is +23.88% above its 3-year low of -$3.76B reached on
- Sector Comparison
- MRNA annual EBITDA is higher than 0.17% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$2.86B | +23.9% | -129.7% | -290.6% | -10000.0% | |
| Quarterly EBITDA | -$1.33B | -31.4% | -374.6% | -203.8% | -10000.0% | |
| TTM EBITDA | -$3.18B | +10.2% | -163.0% | -572.4% | -10000.0% | |
| Price | $45.72 | +73.3% | -63.8% | -71.1% | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $1.94B | -39.9% | -89.8% | +142.0% | +10000.0% | |
| Annual EPS | -$7.25 | +21.8% | -136.1% | -270.3% | +99.8% | |
| $0.00 | +100.0% | -100.0% | +100.0% | +100.0% | ||
| Annual Net Income | -$2.82B | +20.8% | -133.8% | -277.8% | -10000.0% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $9.61B | N/A | -129.7% |
| 5Y | $13.47B | -121.2% | |
| All | $13.47B | -121.2% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$3.76B | +23.9% | |
| 5Y | -$3.76B | +23.9% | |
| All | -$3.76B | +23.9% |
EBITDA History
FAQ
What is the current annual EBITDA of MRNA?
As of today, MRNA annual EBITDA is -$2.86B
What is 1-year change in MRNA annual EBITDA?
MRNA annual EBITDA is up +23.88% year-over-year
What is 3-year change in MRNA annual EBITDA?
MRNA annual EBITDA is down -129.74% over the past 3 years
How far is MRNA annual EBITDA from its all-time high?
MRNA annual EBITDA is currently -121.22% below its historical high of $13.47B set on December 31, 2021
How does MRNA annual EBITDA rank versus sector peers?
MRNA annual EBITDA is higher than 0.17% of companies in Healthcare sector
When is MRNA next annual earnings release?
As of today, the next annual earnings release for MRNA has not been scheduled
Quarterly EBITDA
-$1.33B$539.00M-68.23%
Summary
- Current Value
- As of today, MRNA quarterly EBITDA is -$1.33B, down -68.23% on
- Historical Performance
- MRNA quarterly EBITDA is down -31.45% year-over-year, down -374.64% over the past 3 years
- All-Time High Comparison
- MRNA quarterly EBITDA is currently -124.52% below its historical high of $5.42B set on
- 3-Year Low Comparison
- MRNA quarterly EBITDA is +25.21% above its 3-year low of -$1.78B reached on
- Sector Comparison
- MRNA quarterly EBITDA is higher than 0.09% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$1.33B | -68.2% | -31.4% | -374.6% | -203.8% | |
| Annual EBITDA | -$2.86B | – | +23.9% | -129.7% | -290.6% | |
| TTM EBITDA | -$3.18B | -11.1% | +10.2% | -163.0% | -572.4% | |
| Price | $45.72 | -8.0% | +73.3% | -63.8% | -71.1% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $389.00M | -42.6% | +260.2% | -79.2% | -79.9% | |
| Quarterly EPS | -$3.40 | -61.4% | -35.2% | -1842.7% | -219.7% | |
| $0.00 | +100.0% | +100.0% | +100.0% | -100.0% | ||
| Quarterly Net Income | -$1.34B | -62.6% | -38.3% | -1800.0% | -210.0% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$208.00M | -538.9% | |
| 3Y | $200.00M | -764.5% | |
| 5Y | $5.42B | -124.5% | |
| All | $5.42B | -124.5% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$1.33B | at low | |
| 3Y | -$1.78B | +25.2% | |
| 5Y | -$1.78B | +25.2% | |
| All | -$1.78B | +25.2% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of MRNA?
As of today, MRNA quarterly EBITDA is -$1.33B
What is MRNA quarterly EBITDA most recent change?
MRNA quarterly EBITDA was down -68.23% on March 31, 2026
What is 1-year change in MRNA quarterly EBITDA?
MRNA quarterly EBITDA is down -31.45% year-over-year
How far is MRNA quarterly EBITDA from its all-time high?
MRNA quarterly EBITDA is currently -124.52% below its historical high of $5.42B set on December 31, 2021
How does MRNA quarterly EBITDA rank versus sector peers?
MRNA quarterly EBITDA is higher than 0.09% of companies in Healthcare sector
When is MRNA next earnings release?
The next earnings release for MRNA is on
TTM EBITDA
-$3.18B$318.00M-11.12%
Summary
- Current Value
- As of today, MRNA TTM EBITDA is -$3.18B, down -11.12% on
- Historical Performance
- MRNA TTM EBITDA is up +10.18% year-over-year, down -163.01% over the past 3 years
- All-Time High Comparison
- MRNA TTM EBITDA is currently -119.29% below its historical high of $16.47B set on
- 3-Year Low Comparison
- MRNA TTM EBITDA is +30.48% above its 3-year low of -$4.57B reached on
- Sector Comparison
- MRNA TTM EBITDA is higher than 0.18% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$3.18B | -11.1% | +10.2% | -163.0% | -572.4% | |
| Annual EBITDA | -$2.86B | – | +23.9% | -129.7% | -290.6% | |
| Quarterly EBITDA | -$1.33B | -68.2% | -31.4% | -374.6% | -203.8% | |
| Price | $45.72 | -8.0% | +73.3% | -63.8% | -71.1% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $2.23B | +14.4% | -30.0% | -85.1% | -18.6% | |
| TTM EPS | -$8.15 | -12.2% | +6.6% | -170.3% | -749.7% | |
| -$2.02B | +34.2% | +45.7% | -143.1% | -419.4% | ||
| TTM Net Income | -$3.19B | -13.2% | +4.9% | -166.8% | -634.0% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$2.86B | -11.1% | |
| 3Y | $5.04B | N/A | -163.0% |
| 5Y | $16.47B | -119.3% | |
| All | $16.47B | -119.3% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$3.54B | N/A | +10.2% |
| 3Y | -$4.57B | +30.5% | |
| 5Y | -$4.57B | +30.5% | |
| All | -$4.57B | +30.5% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of MRNA?
As of today, MRNA TTM EBITDA is -$3.18B
What is MRNA TTM EBITDA most recent change?
MRNA TTM EBITDA was down -11.12% on March 31, 2026
What is 1-year change in MRNA TTM EBITDA?
MRNA TTM EBITDA is up +10.18% year-over-year
How far is MRNA TTM EBITDA from its all-time high?
MRNA TTM EBITDA is currently -119.29% below its historical high of $16.47B set on March 31, 2022
How does MRNA TTM EBITDA rank versus sector peers?
MRNA TTM EBITDA is higher than 0.18% of companies in Healthcare sector
When is MRNA next earnings release?
The next earnings release for MRNA is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- MRNA Official Website www.modernatx.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1682852/000162828025053816/0001628280-25-053816-index.htm
- MRNA Profile on Yahoo Finance finance.yahoo.com/quote/MRNA
- MRNA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mrna